Preparation of whole cell lysates and nuclear extracts, gel electrophoresis and electroblotting were performed as previously reported (Sasagawa et al., 2018 (link)). The following primary antibodies were used: anti-HIF-1α (1:500, #3716; Cell Signaling Technology, Beverly, MA, USA), anti-HIF-2α (1:1000, NB100-122; Novus Biologicals, Littleton, CO, USA), anti-HIF-1β (1:2000, NB100-110; Novus Biologicals), anti-β-actin (1:1000, #4967; Cell Signaling Technology), anti-TATA binding protein (1:200, sc-421; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-human FLT1 N-terminal region (rabbit polyclonal) antibody (1:1000) (Tanaka et al., 1997 (link); Sasagawa et al., 2018 (link); Sasagawa et al., 2020 (link)).